FOR IMMEDIATE RELEASE II
Chief Executive Lawrence Ho will resume his duties on Monday, July 27, 2026. Following a successful recovery, Lawrence Ho will return to lead the company, while Pedin Xie will conclude the role of Acting Chief Executive.
Section / press-release
Press Release
2 articles
FOR IMMEDIATE RELEASE I
Chief Executive will undergo surgery on Monday, July 19, 2026. Pedin Xie has been appointed Acting Chief Executive.